Titan Biotech Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 303.33 million compared to INR 364.27 million a year ago. Revenue was INR 306.12 million compared to INR 366.55 million a year ago. Net income was INR 32.62 million compared to INR 52.31 million a year ago. Basic earnings per share from continuing operations was INR 3.95 compared to INR 6.33 a year ago. Diluted earnings per share from continuing operations was INR 3.95 compared to INR 6.33 a year ago.
For the nine months, sales was INR 1,071.63 million compared to INR 1,198.74 million a year ago. Revenue was INR 1,086.14 million compared to INR 1,205.02 million a year ago. Net income was INR 198.93 million compared to INR 203.46 million a year ago. Basic earnings per share from continuing operations was INR 24.07 compared to INR 24.62 a year ago. Diluted earnings per share from continuing operations was INR 24.07 compared to INR 24.62 a year ago.